Morgan Stanley Maintains Overweight on Marriott International, Raises Price Target to $431
Morgan Stanley analyst Stephen Grambling maintains Marriott International (NASDAQ:MAR) with a Overweight and raises the price target from $403 to $431.
Follow the latest Marriott International (MAR) news and market headlines alongside the live MAR price. Stay informed on what's moving MAR.
Morgan Stanley analyst Stephen Grambling maintains Marriott International (NASDAQ:MAR) with a Overweight and raises the price target from $403 to $431.
CNBC final trades feature Berkshire Hathaway, Amazon, AbbVie and Marriott, backed by analyst upgrades, strong earnings and growth plans.
Bernstein analyst Richard Clarke maintains Marriott International (NASDAQ:MAR) with a Outperform and raises the price target from $445 to $479.
Marriott International (NASDAQ:MAR) has outperformed the market over the past 20 years by 2.97% on an annualized basis producing an average annual return of 11.71%. Currently, Marriott International has a market
The article compares American Express and S&P Global as investment options for 2027. American Express operates a closed-loop payment network with $72.2B in FY2025 revenue and 15% net margins, benefiting from premium consumer spending. S&P Global provides financial ratings and data with $15.3B in FY2025 revenue and superior 29.2% net margins, benefiting from passive investing growth. The author recommends American Express for its younger customer base and different growth driver, while S&P Global suits investors seeking exposure to passive investing trends.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to MAR, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.